Science Explorer Interactive view Map
Company · Mataró · Spain

Palobiofarma (Spain)

Research works
29
▲ 14% vs 2013–17
Citations
749
26.1 per fractional work
Top-10% rate
12.1%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Palobiofarma (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.05× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 3.42× its world share, 0 worksNeuroscienceMedicine: 1.98× its world share, 1 worksMedicinePsychology: 1.07× its world share, 0 worksPsychologySocial Sciences: 1.71× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.

Which keywords describe research at Palobiofarma (Spain)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Tumor Microenvironment, Cancer, Cardiovascular Risk, Antioxidant, Chemoprevention, Biogeography and Phylogeny.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Inflammation5▲ 8.1×11 topics
  2. Cancer2▲ 6.3×4 topics
  3. Tumor Microenvironment2▲ 24×4 topics
  4. Epidemiology2▲ 2.0×8 topics
  5. Cardiovascular Risk2▲ 19×3 topics
  6. Antioxidant2▲ 9.1×6 topics
  7. Biogeography2▲ 17×3 topics
  8. Chemoprevention2▲ 68×2 topics
  9. Phylogeny2▲ 32×3 topics
  10. Neuroprotection2▲ 14×4 topics
  11. Therapeutic Targets2▲ 24×2 topics
  12. Clinical Trials2▲ 8.3×5 topics
  13. Pharmacology2▲ 15×6 topics
  14. Cyclooxygenase-2 Inhibitors1▲ 125×1 topic
  15. Prostaglandins1▲ 125×1 topic
  16. Adenosine Receptors1▲ 172×1 topic
  17. Purinergic Signalling1▲ 172×1 topic
  18. Taxonomy1▲ 27×2 topics
  19. Cervical Cancer1▲ 38×2 topics
  20. Global Burden1▲ 7.1×2 topics
  21. Metabolism1▲ 6.0×5 topics
  22. Oxidative Stress1▲ 2.0×6 topics
  23. Treatment1▲ 3.0×4 topics
  24. Brassicaceae1▲ 468×1 topic
  25. Ethical Climate1▲ 83×1 topic
  26. HPV Vaccination1▲ 71×1 topic
  27. Human Papillomavirus1▲ 29×1 topic
  28. Medicinal Plants1▲ 9.4×3 topics
  29. Moral Distress1▲ 83×1 topic
  30. molecular systematics1▲ 136×1 topic

Which research topics does Palobiofarma (Spain) publish most on?

By volume in 2022–2025: Adenosine and Purinergic Signaling, Peptidase Inhibition and Analysis, Data Privacy and Cybersecurity and Cancer Immunotherapy and Biomarkers.

  1. 1 Adenosine and Purinergic Signaling Physiology 0 works
  2. 2 Peptidase Inhibition and Analysis Oncology 0 works
  3. 3 Data Privacy and Cybersecurity Law 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 Administrative Law and Governance Political Science and International Relations 0 works
  6. 6 Agriculture and Biological Studies General Agricultural and Biological Sciences 0 works
  7. 7 Genetic diversity and population structure Genetics 0 works
  8. 8 Botanical Studies and Applications Plant Science 0 works
  9. 9 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Palliative and Oncologic Care Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.7%not open52.3%

World: 28% of research is openly available.

with international co-authors43.4%domestic only56.6%

World: 19% is written across borders.

How has Palobiofarma (Spain)'s research output changed?

Output in 2018–2022 was 14% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mataró

All research institutions in Mataró

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.